
"Potential Breakthrough: Blocking Key Protein Halts Alzheimer's Progression"
Researchers at the University of Colorado Anschutz Medical Campus have discovered that inhibiting a protein called Mdm2 with an experimental cancer drug can prevent the destruction of synapses and dendritic spines associated with Alzheimer's disease. This finding suggests a potential new approach to halting the progression of the disease, which could lead to future human trials and the development of new therapies.
